Sanna Rydberg - Arcoma AB Chief Officer

ARCOMA Stock  SEK 10.45  0.20  1.88%   

Insider

Sanna Rydberg is Chief Officer of Arcoma AB
Age 54
Phone46 4 70 70 69 00
Webhttps://www.arcoma.se

Arcoma AB Management Efficiency

The company has return on total asset (ROA) of 0.0218 % which means that it generated a profit of $0.0218 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0423 %, meaning that it generated $0.0423 on every $100 dollars invested by stockholders. Arcoma AB's management efficiency ratios could be used to measure how well Arcoma AB manages its routine affairs as well as how well it operates its assets and liabilities.
Arcoma AB has accumulated 1.81 M in total debt with debt to equity ratio (D/E) of 0.43, which is about average as compared to similar companies. Arcoma AB has a current ratio of 1.43, which is within standard range for the sector. Debt can assist Arcoma AB until it has trouble settling it off, either with new capital or with free cash flow. So, Arcoma AB's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Arcoma AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Arcoma to invest in growth at high rates of return. When we think about Arcoma AB's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Thomas JoyceDignitana AB
N/A
Cameron OMaraDignitana AB
44
Christian LindgrenDignitana AB
49
Maria EdholmGenovis AB
N/A
BA BAGenovis AB
N/A
Susanne AhlbergGenovis AB
66
Sofia AruAvensia publ AB
N/A
Magnus LangbergGenovis AB
52
Patrik SundquistAvensia publ AB
36
Anette CronstroemDignitana AB
N/A
Jane WallDignitana AB
N/A
Fredrik AndreAvensia publ AB
50
Johan JohanssonDignitana AB
N/A
Gunilla SavringaXichem AB
61
Erik LageraXichem AB
48
John AndersonStille AB
48
Jrgen BertilssonAvensia publ AB
51
Lisa LogrenAvensia publ AB
N/A
Rikke RytterGenovis AB
56
Hanna WilkmanStille AB
56
Lucas AltepostaXichem AB
56
Arcoma AB develops, produces, and provides radiology solutions worldwide. It offers digital x-ray and radiography systems for radiographic applications, as well as for use in general, eneral, muscleskeleton, thoratic, pediatric, and traumaresus clinics. Arcoma AB is traded on Stockholm Stock Exchange in Sweden. Arcoma AB (ARCOMA) is traded on Stockholm Exchange in Sweden and employs 24 people.

Management Performance

Arcoma AB Leadership Team

Elected by the shareholders, the Arcoma AB's board of directors comprises two types of representatives: Arcoma AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Arcoma. The board's role is to monitor Arcoma AB's management team and ensure that shareholders' interests are well served. Arcoma AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Arcoma AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
Frida Robbe, Marketing Mang
Sanna Rydberg, Chief Officer
Johan Dahlberg, Chief Officer
Peter Reinli, Pres IMIX ADR Ltd
Nicklas Johansson, Operations Manager

Arcoma Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Arcoma AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Other Information on Investing in Arcoma Stock

Arcoma AB financial ratios help investors to determine whether Arcoma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Arcoma with respect to the benefits of owning Arcoma AB security.